Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07262775 · ClinicalTrials.gov registry record · NA
Radicle Relief RAL™: A Study Assessing the Impact of Health and Wellness Products on Pain Relief and Related Health Outcomes
A NA study, sponsored by Radicle Science.
- Active
- Registry status
- NA
- Development phase
- 715
- Enrollment target
NCT07262775: Active NA study, sponsored by Radicle Science.
NCT07262775 is a NA study that is active but no longer recruiting, run by Radicle Science. The registered enrollment target is 715 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07262775, a NA study, is active but no longer recruiting, sponsored by Radicle Science.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 715 participants
- Enrollment target
Study Summary
Radicle Relief RAL: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on pain relief and related health outcomes.
Primary Outcome
Change in Pain Interference: Difference in rates of change over time in pain interference score as assessed by PROMIS Pain Interference 6A (scale 6-30; with higher scores corresponding to more severe pain interference)
Interventions
- DIETARY_SUPPLEMENT Pain Relief Supplement Product Placebo Control
- DIETARY_SUPPLEMENT Pain Relief Supplement Active Product 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 715 participants |
| Start Date | 2025-12-18 |
| Est. Completion | 2027-01-04 |
| Phase | NA |
What the registry record for NCT07262775 still lists
NCT07262775 is an interventional study that assigns participants to a tested intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (49% lower).
The record links to 0 conditions, and to 2 interventions - of which Pain Relief Supplement Product Placebo Control is the first listed.
NCT07262775 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07262775 about?
NCT07262775 is a clinical study titled "Radicle Relief RAL™: A Study Assessing the Impact of Health and Wellness Products on Pain Relief and Related Health Outcomes". Radicle Relief RAL: A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on pain relief and related health outcomes.
What is the current status of trial NCT07262775?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 715 participants. The study started on 2025-12-18. Estimated completion is 2027-01-04.
What interventions are being tested in trial NCT07262775?
The interventions under investigation include: Pain Relief Supplement Product Placebo Control (DIETARY_SUPPLEMENT), Pain Relief Supplement Active Product 1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07262775?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07262775's enrollment target sits among peer trials
715 147th of 2000 higher than 1,854 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04680000 · 716 participants · NA
Chronic Pain Management In Primary Care Using Behavioral Health Consultants
- NCT05208762 · 714 participants · Phase 1
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- NCT06758401 · 714 participants · Phase 3
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- NCT04916327 · 720 participants · NA
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI